Dental imaging company expanding availability of its products in North America.
Vatech’s portfolio of imaging products will now be distributed by Henry Schein, a move that was announced this week and will help the South Korean manufacturer to expand the availability of its products for dental clinics in North America.
Vatech's product offerings to be distributed to Henry Schein customers will include, Green CT, a low dose cone beam solution, featuring fast scanning and high-resolution image quality, and EzRay Air, an intraoral x-ray solution and imaging center that uses CNT x-ray technology. The company’s diverse product portfolio includes intraoral devices, 2D and 3D CT devices, and dental software, all widely used in dental offices around the globe.
"Vatech looks forward to growing our relationship with Henry Schein, delivering our portfolio of imaging products that can help enhance diagnosis accuracy and treatment efficiency," says Brian Hwang, president of Vatech America, in a press release. "Our commitment to providing systematic and customer-centric service will only continue to strengthen thanks to the depth of Henry Schein's reach, and its aligned interests in continuing to expand globally."
Vatech's various products were demonstrated for oral health professionals at Henry Schein's THRIVELIVE™ event in May in Las Vegas, Nevada, and at the IDS Dental Meeting in March in Cologne, Germany.
The company’s 2D imaging solutions include PaX-i and PaX-i Plus, while Vatech also offers the HD Sensor and Wave Sensor x-ray sensors, and imaging software products for improved diagnosis, treatments, and patient consultation.
"Henry Schein is excited to work with Vatech and expand our imaging solutions for customers," Mackenzie Richter, Vice President of Equipment, Henry Schein Dental," says in the press release. “Vatech's diverse product portfolio, including intraoral devices, 2D and 3D CT devices, and dental software will help us continue to strengthen our customers' diagnostic imaging solutions, allowing for more precise treatment planning."